HR 434, the Service Restoration Act, protects military service members and academy cadets/midshipmen who refused a COVID-19 vaccine and were involuntarily separated. It prohibits using federal funds to mandate the vaccine, bans adverse actions (like separation or demotion) for refusal, and requires the military to reinstate affected individuals to their previous rank and grade with back pay. The bill also mandates that any separation for vaccine refusal be retroactively reclassified as an "honorable discharge" and removes all related records from service files. This applies specifically to those separated solely for vaccine refusal between 2021 and the bill's enactment.
Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.
HR 441, the Leak and Lose Act of 2023, makes it a federal crime to conceal, remove, destroy, or alter unpublished Supreme Court opinions or draft opinions before they are officially published. The bill targets anyone who willfully engages in these actions while handling such materials within Supreme Court buildings. Violators face a $5,000 fine and lose the right to practice law in any federal court for life. This law directly affects individuals with access to Supreme Court documents, such as clerks or staff, by imposing severe professional penalties for mishandling sensitive court materials.
Teleabortion Prevention Act of 2023 This bill restricts the use of telehealth for chemical abortions (also known as medication abortions). Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition. The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements. A patient who undergoes a chemical abortion may not be prosecuted.
Standardizing Thresholds Of Penalties for Fentanyl Act or the STOP Fentanyl Act This bill reduces the drug quantity thresholds that trigger a mandatory minimum prison term for a defendant who manufactures, distributes, imports, exports, or possesses with intent to distribute fentanyl. The bill also creates enhanced criminal penalties for certain violations involving fentanyl that was imported along the U.S.-Mexico border. Specifically, the bill reduces from 400 to 5 grams the fentanyl quantity and from 100 to 0.05 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for high-level first-time or repeat offenders. It also reduces from 40 to 0.5 grams the fentanyl quantity and from 10 to 0.005 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for low-level first-time or repeat offenders. Additionally, the bill creates enhanced mandatory minimum prison terms for importing or exporting fentanyl that was imported along the U.S.-Mexico border.
HR 330, the Title X Abortion Provider Prohibition Act, prohibits federal funding under the Title X family planning program for clinics that perform or fund abortions, except in cases of rape, incest, or when a physician certifies a life-threatening condition. It requires clinics receiving Title X funds to certify they do not provide or fund abortions (with the specified exceptions), and hospitals are exempt if they don't fund non-hospital abortion providers. The bill mandates annual reports to Congress listing all funded clinics, the number of abortions performed under exceptions (including rape/incest cases), and the certification dates for each clinic. This directly affects Title X-funded clinics nationwide that provide abortion services or fund such services, altering their eligibility for federal funding. The law aims to restrict federal support for abortion access within the Title X program while maintaining limited exceptions.
HR 279, the Pharmacist Conscience Protection Act, protects pharmacists, pharmacy technicians, and pharmacy owners who refuse to dispense medications approved for abortion or that they believe may be used for abortion, based on moral, religious, or medical objections. The bill prohibits federal agencies and entities receiving federal funds (including state/local governments) from discriminating against, penalizing, or retaliating against these providers for such refusals. It does not require pharmacists to dispense these medications and explicitly preserves stronger state conscience protections. This law directly affects pharmacists and pharmacies seeking to align their practice with personal or religious beliefs regarding abortion-related medications.
HR 286, the Health Care Providers Safety Act of 2023, provides federal grants to healthcare providers to improve security at their facilities. The bill authorizes the Secretary to fund security services and physical/cyber security enhancements, including video surveillance, data privacy measures, and structural improvements. These grants directly help healthcare facilities, personnel, and patients by addressing safety concerns. The law specifies that funds must be used for necessary security costs to ensure safe access to healthcare services. It does not create new mandates but offers financial support for security upgrades.
Triple-Negative Breast Cancer Research and Education Act of 2023 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
HR 128, the Defund Planned Parenthood Act of 2023, blocks federal funding to Planned Parenthood Federation of America and its affiliates for one year unless they certify they will not perform or fund abortions (except in cases of rape, incest, or life-threatening conditions for the patient). This directly affects Planned Parenthood clinics and their federal funding streams. The bill redirects $235 million to community health centers under the Public Health Service Act to continue providing women’s health services like contraception, cancer screenings, and prenatal care. It requires repayment of funds if Planned Parenthood violates the certification and explicitly states the law won’t reduce overall federal funding for women’s health services.
HR 167 allows pharmacies to compound drugs for urgent hospital use without a specific patient prescription under strict conditions. It requires hospitals to certify they couldn’t obtain FDA-approved or outsourcing-facility alternatives for the same active ingredient and route of administration. Compounded drugs must be labeled with a beyond-use date, marked for urgent use only, and hospitals must track patient administration within 7 days while reporting adverse events to the FDA within 15 days. This directly affects hospitals, pharmacists, and physicians during drug shortages, enabling faster access to necessary medications while maintaining safety and tracking requirements.
This resolution urges all participants in the Good Friday agreement and subsequent agreements to honor their obligations. The resolution also supports efforts to (1) prevent a hard border within the island of Ireland and (2) promote peace and prosperity for all communities. (The island of Ireland is divided between Northern Ireland, which is part of the United Kingdom, and the Republic of Ireland, a European Union member state.)
